BELLICUM PHARMACEUTICALS INC's ticker is BLCM and the CUSIP is 079481107. A total of 53 filers reported holding BELLICUM PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $16,000 | -80.0% | 1,200 | -70.0% | 0.01% | -80.6% |
| Q3 2016 | $80,000 | -4.8% | 4,000 | -38.5% | 0.07% | -6.5% |
| Q2 2016 | $84,000 | +37.7% | 6,500 | 0.0% | 0.08% | +35.1% |
| Q1 2016 | $61,000 | -53.8% | 6,500 | 0.0% | 0.06% | -53.7% |
| Q4 2015 | $132,000 | -56.1% | 6,500 | -68.7% | 0.12% | -56.8% |
| Q3 2015 | $301,000 | -26.4% | 20,750 | +7.8% | 0.28% | -22.3% |
| Q2 2015 | $409,000 | +194.2% | 19,250 | +220.8% | 0.37% | +205.8% |
| Q1 2015 | $139,000 | -7.3% | 6,000 | -7.7% | 0.12% | -7.0% |
| Q4 2014 | $150,000 | – | 6,500 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Avoro Capital Advisors LLC | 220,000 | $5,069,000 | 3.43% |
| Perceptive Advisors | 1,046,402 | $24,109,000 | 2.02% |
| Redmile Group, LLC | 860,809 | $17,269,000 | 1.88% |
| Baker Brothers Advisors | 4,283,732 | $98,697,000 | 1.01% |
| RA Capital Management | 1,026,402 | $9,337,000 | 1.00% |
| Ghost Tree Capital, LLC | 75,000 | $1,728,000 | 0.83% |
| ACUTA CAPITAL PARTNERS, LLC | 45,750 | $1,054,000 | 0.71% |
| GREAT POINT PARTNERS LLC | 50,000 | $1,152,000 | 0.55% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 167,210 | $3,853,000 | 0.33% |
| EMERALD ADVISERS, LLC | 198,202 | $4,567,000 | 0.24% |